In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
The in vitro activity of several new imidazoles, cloconazole, sulconazole, butoconazole, isoconazole and fenticonazole, were compared with those of amphothericin B, flucytosine, and three azoles: econazole, miconazole and ketoconazole against isolates of pathogenic Candida. A total of 186 clinical isolates of 10 species of the genus Candida and two culture collection strains were tested by an agar-dilution technique. Isoconazole was the most active azole, followed by butoconazole sulconazole. Differences between some of the species in their susceptibility to the antifungal agents were noted. Sulconazole and cloconazole had the highest activity in vitro against 106 isolates of C. albicans. Butoconazole and isoconazole were also very active against isolates of C. albicans, and were the most active azole compounds against 80 isolates of Candida spp.
Hernández Molina
J M
JM
Servicio de Microbiología, Hospital General Virgen de las Nieves, Granada, Spain.
Llosá
J
J
Martinez Brocal
A
A
Ventosa
A
A
D000666:Amphotericin B / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects*; D002176:Candida albicans / Q000187:drug effects*; D004464:Econazole / Q000494:pharmacology; D005437:Flucytosine / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology*; D007654:Ketoconazole / Q000494:pharmacology; D008825:Miconazole / Q000031:analogs & derivatives / Q000494:pharmacology; D008826:Microbial Sensitivity Tests
D000935:Antifungal Agents; D007093:Imidazoles; C017125:butoconazole; C038008:croconazole; C033308:sulconazole; D004464:Econazole; D008825:Miconazole; D000666:Amphotericin B; D005437:Flucytosine; C020382:isoconazole; C033486:fenticonazole; D007654:Ketoconazole